Is Ama­zon plan­ning to dis­rupt the $560B pre­scrip­tion drug mar­ket?

All the buzz out of Ama­zon these days in­di­cates that the on­line jug­ger­naut is look­ing to dis­rupt the gi­ant US health­care mar­ket. And now the rum­blings point to a po­ten­tial Ama­zon earth­quake in the $560 bil­lion pre­scrip­tion phar­ma­ceu­ti­cals mar­ket.

Gold­man Sachs as­sem­bled a 30-page re­port that es­sen­tial­ly out­lined how Ama­zon could re­vamp an in­dus­try not­ed for its puz­zling pric­ing mod­els, with po­ten­tial for rev­o­lu­tion­iz­ing the way Amer­i­cans or­der and get their drugs on a mass scale. Phar­ma­cies would be un­like­ly to cel­e­brate any of this, but the an­a­lysts see Ama­zon’s en­try as one way to solve the puz­zle on pric­ing trans­paren­cy, while open­ing up broad ac­cess to a huge mar­ket with lots of cross-sell­ing po­ten­tial.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER